|
已选(0)清除
条数/页： 排序方式： |
| Long-term outcomes of a phase II randomized controlled trial comparing intensity-modulated radiotherapy with or without weekly cisplatin for the treatment of locally recurrent nasopharyngeal carcinoma 期刊论文
CHINESE JOURNAL OF CANCER, 2016, 卷号: 35
-
  收藏 | 浏览/下载：27/0 | 提交时间：2020/10/26
CONCURRENT CHEMORADIOTHERAPY PROGNOSTIC-FACTORS RADIATION-THERAPY NECK-CANCER REIRRADIATION CHEMOTHERAPY SURVIVAL METAANALYSIS RETREATMENT HEAD Recurrence Nasopharyngeal carcinoma Intensity-modulated radiation therapy Concomitant chemoradiotherapy Cisplatin |
| ABO blood group is a predictor of survival in patients with laryngeal cancer 期刊论文
CHINESE JOURNAL OF CANCER, 2016, 卷号: 35
-
收藏 | 浏览/下载：24/0 | 提交时间：2020/10/26
GENOME-WIDE ASSOCIATION SQUAMOUS-CELL CARCINOMA PANCREATIC-CANCER NASOPHARYNGEAL CARCINOMA COHORT CONSORTIUM CHINESE PATIENTS GROUP ALLELES RISK POPULATION EXPRESSION The ABO blood group Laryngeal cancer Prognosis Survival |
| A new prognostic histopathologic classification of nasopharyngeal carcinoma 期刊论文
CHINESE JOURNAL OF CANCER, 2016, 卷号: 35
-
收藏 | 浏览/下载：26/0 | 提交时间：2020/10/26
CONCURRENT CISPLATIN-RADIOTHERAPY ADJUVANT CHEMOTHERAPY RANDOMIZED-TRIAL STAGING SYSTEM CANCER CHEMORADIOTHERAPY METAANALYSIS CHINA SURVIVAL UNION Nasopharyngeal carcinoma Pathologic classification Prognosis |
| Subdivision of M category for nasopharyngeal carcinoma with synchronous metastasis: time to expand the M categorization system 期刊论文
CHINESE JOURNAL OF CANCER, 2015, 卷号: 34
-
收藏 | 浏览/下载：37/0 | 提交时间：2020/10/26
PRIMARY TUMOR VOLUME EPSTEIN-BARR-VIRUS RADIOFREQUENCY ABLATION PROGNOSTIC-FACTORS RADIATION-THERAPY LIVER METASTASES STAGING SYSTEM SURVIVAL CANCER CHEMOTHERAPY Nasopharyngeal carcinoma TNM staging Metastasis Prognosis |
| Efficacy of minimally invasive therapies on unresectable pancreatic cancer 期刊论文
CHINESE JOURNAL OF CANCER, 2013, 卷号: 32
-
收藏 | 浏览/下载：31/0 | 提交时间：2020/10/26
LIVER METASTASES NASOPHARYNGEAL CARCINOMA RADIOFREQUENCY ABLATION CHEMOTHERAPY GEMCITABINE TUMORS MANAGEMENT SURVIVAL Pancreatic cancer minimally invasive therapies transarterial chemoembolization radiofrequency ablation median survival |
